Gene amplification of int-2 and erbB in human esophageal cancer: Relationship to clinicopathological variables

Cancer Investigation

Volumn 15, Issue 5, 1997, Pages 411-415

  Suzuki, Hiroyuki ^a   Abo, Shichisaburo ^a   Kitamura, Michihiko ^a   Hashimoto, Masaji ^a   Izumi, Keiichi ^a   Terada, Kunihiko ^a   Sugiyama, Toshihiro ^a  

^a AKITA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; ESOPHAGUS CANCER; ESOPHAGUS MUCOSA; FEMALE; GENE AMPLIFICATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; METASTASIS; PRIORITY JOURNAL; PROTO ONCOGENE; SOUTHERN BLOTTING; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

EID: 0030853587     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909709047579     Document Type: Article

References (29)

1. Lu S-H, Hsieh L-L, Luo F-C, et al: Amplification of the EGF receptor and c-myc genes in human esophageal cancers. Int J Cancer 42:502-505, 1988.
2. Tsuda T, Tahara E, Kajiyama G, Sakamoto H, et al: High incidence of coamplification of hst-1 and int-2 genes in human esophageal carcinomas. Cancer Res 49:5505-5508, 1989.
3. Wagata T, Ishizaki K, Imamura M, et al: Deletion of 17p and amplification of the int-2 gene in esophageal carcinomas. Cancer Res 51:2113-2117, 1991.
4. Kitagawa Y, Ueda M, Ando N, et al: Significance of int-2/hst-1 coamplification as a prognostic factor in patients with esophageal squamous carcinoma. Cancer Res 51:1504-1508, 1991.
5. Hollstein MC, Smits AM, Galiana C, et al: Amplification of epidermal growth factor receptor gene but no evidence of ras mutations in primary human esophageal cancers. Cancer Res 48:5119-5123, 1988.
6. Mukaida H, Toi M, Hirai T, et al: Clinical significance of the expression of epidermal growth factor and its receptor in esophageal cancer. Cancer 68:142-148, 1991.
7. Hollstein MC, Metcalf RA, Welsh JA, et al: Frequent mutation of the p53 gene in human esophageal cancer. Proc Natl Acad Sci USA 87:9958-9961, 1990.
8. Meltzer SJ, Yin J, Huang Y, et al: Reduction to homozygosity involving p53 in esophageal cancers demonstrated by polymerase chain reaction. Proc Natl Acad Sci USA 88:4976-4980, 1991.
9. Huang Y, Boynton RF, Blount PL, et al: Loss of heterozygosity involves multiple tumor suppressor genes in human esophageal cancers. Cancer Res 52:6525-6530, 1992.
10. Blount PL, Galipeau PC, Sanchez CA, et al: 17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy. Cancer Res 54:2292-2295, 1994.
11. Hollstein M, Sidransky D, Vogelstein B, et al: p53 mutations in human cancers. Science 253:49-53, 1991.
12. Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual, Cold Spring Harbor, NY, Cold Spring Harbor Laboratory Press, 1989.
13. Feinberg AP, Vogelstein BA: Technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132:6-13, 1983.
14. Southern EM: Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 98:503-517, 1975.
15. Casey G, Smith R, McGillivray D, et al: C. Characterization and chromosome assignment of the human homolog of int-2, a potential proto-oncogene. Mol Cell Biol 6:502-510, 1986.
16. Xu Y-H, Richert N, Ito S, et al: Characterization of epidermal growth factor receptor gene expression in malignant and normal human cells. Proc Natl Acad Sci USA 81:7308-7312, 1984.
17. Japanese Society for Esophageal Diseases: Guidelines for the Clinical and Pathologic Studies on Carcinoma of the Esophagus, 8th ed, Kanehara Co. Ltd., 1992.
18. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Statist Assoc 53:457-481, 1958.
19. Gehan E: A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika 52:203-224, 1956.
20. Suzuki H, Abo S, Kitamura M, et al: Analysis of gene amplification in human esophageal cancer. In: Recent Advances in Diseases of the Esophagus, edited by K Nabeya, T Hanaoka, H Nogami, New York, Springer-Verlag, 1993, pp 448-453.
21. Ali IU, Merlo G, Callahan R, et al: The amplification unit on chromosome 11q13 in aggressive primary human breast tumors entails the bcl-1, int-2 and hst loci. Oncogene 4:89-92, 1989.
22. Zhou DJ, Casey G, Cline MJ: Amplification of int-2 gene in breast cancers and squamous cell carcinomas. Oncogene 2:279-282, 1988.
23. Tsutsumi M, Sakamoto H, Yoshida T, et al: Coamplification of the hst-1 and int-2 genes in human cancers. Jpn J Cancer Res 79:428-432, 1988.
24. Adelaide J, Mattei MG, Maries I, et al: Chromosomal localization of the hst oncogene and its co-amplification with the int-2 oncogene in human melanoma. Oncogene 2:413-416, 1988.
25. Yoshida MC, Wada M, Satoh H, et al: Human HST-1 (HSTF1) gene maps to chromosome band 11q13 and coamplifies with the INT-2 gene in human cancer. Proc Natl Acad Sci USA 85:4861-4864, 1988.
26. Hatada I, Tokino T, Ochiya T, et al: Coamplification of integrated hepatitis B virus DNA and transforming gene hst-1 in a hepatocellular carcinoma. Oncogene 3:537-540, 1988.
27. Jiang W, Kahn SM, Tomita N, et al: Amplification and expression of the human cyclin D gene in esophageal cancer. Cancer Res 52:2980-2983, 1992.
28. Ozawa S, Ueda M, Ando N, et al: Epidermal growth factor receptors in cancer tissues of esophagus, lung, pancreas, colorectum, breast and stomach. Jpn J Cancer Res 79:1201-1207, 1988.
29. Downward J, Yarden Y, Mayes E, et al: Close similarity of epidermal growth factor receptor and v-erbB oncogene protein sequences. Nature 307:521-527, 1984.